D. Wei-Tsao

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

F M Muggia, A. Gabizon, Z. Yehoshua, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Salvage chemotherapy with CPT‐11 for recurrent temozolomide‐refractory anaplastic astrocytoma

M. Chamberlain, D. Blumenthal, M. Glantz, 2008, Cancer.

RECIST 1.0 versus 1.1: Implications for trial interpretation and design in advanced prostate cancer.

J. Pinski, T. Dorff, H. Jadvar, 2011, Journal of Clinical Oncology.